We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We may also share information about your use of our site with our social media, advertising and analytics partners. Read more about our Privacy Policy.

I got it!

5th Annual Biosmilars USA

Developments in Biosimilars Drug Development

Building on the success of previous events, SMi proudly announces the return of its 5th Annual Biosimilars USA Conference, taking place in New Jersey on the 14th and 15th November 2018.

This fifth annual event will gather a global audience of biosimilar experts and industry-thought leaders to discuss biosimilar manufacturing and commercialization considerations specific to the

Fresh from the press: On March 7th, 2018, the ;s Commissioner, Scott Gottlieb, MD, announced that Biosimilar medicines are now a top priority for the FDA. Join us this November to learn how to take advantage of the FDA’s focus on biosimilars, accelerate your biosimilar pipeline and achieve FDA approval.

Hear from a selection of carefully handpicked keynote addresses and case studies presented to you by top manufacturing and leading distributors of market approved biosimilars, as they offer a unique insight into the areas of manufacturing, commercialization, device design, uptake, switching, interchangeability, and regulations.

This event is CPD accredited.

#SMiBioSimUSA


PLUS TWO INTERACTIVE HALF-DAY PRE-CONFERENCE WORKSHOPS
Tuesday 25th September 2018, Copthorne Tara Hotel, Central London, UK

- Workshop A: Decoding how Stakeholders may Drive Biosimilar Adoption
Workshop Leaders: Tucker Herbert, Manager, ZS Associates
Christina Corridon,
Associate Principal, ZS Associates

- Workshop B: Dealing with Life Sciences Patents at the PTAB
Workshop Leaders: Ha Kung Wong, Partner, New York, Fitzpatrick, Cella, Harpper & Scinto
John Kirkland,
Director, Intellectual Property, Alkermes, Inc.

WHO SHOULD ATTEND
Medical Directors, Scientific Directors, VP’s, Directors, Managers, Team Leaders, Partners, Consultants and Attorneys of:
Biosimilars, Biobetters, Biopharmaceuticals, Biostatistics, Business Alliances, Business Development, Clinical Operations, Commercial, Decision Analytics, Global Intelligence, Global Operations, Managed Markets and Trade Relations, Market assess, Marketing, Patient & Physician Services, R&D Policy, Regulatory Affairs, Scientific Affairs, and anyone else who works within the biosimilars industry! 

EARLY BIRD-RATES

  • Summer Special SAVE US$200 visit website and use voucher code BIOUSA200OFF​ 
  • BOOK BY SEPTEMBER 28TH AND SAVE US$100

Visit  to register and to download the brochure with full line-up of ; 

When

14 Nov 2018 @ 08:30 am

15 Nov 2018 @ 05:00 pm

Duration: 1 days, 8 hours


Where

Renaissance Woodbridge Hotel

U.S. 1

United States


Organised by

SMi Group Ltd.

Premium Events in Science

Recent Publications in Science

Recent Videos in Science

Recent News in Science

NIA’s Director of Regulatory Affairs, David Carlander on regulatory issues that may arise in the field of #textiles… https://t.co/jlysdZ7xTr

@nanotechia - 15 Nov 2018 14:53

Matthew Tipper from Non-wovens Innovation & Research Institute Ltd (NIRI) is discussing how functionality can be ad… https://t.co/Q86Hfg5as7

@nanotechia - 15 Nov 2018 14:12

The Nextflow workshop is around the corner! Last round of speakers: Antonio Puertas Gallardo will talk about bioinf… https://t.co/F46VrEAl5O

@EU_ScienceHub - 15 Nov 2018 14:12

Recent Speakers in Science

Premium Eventslearn more ..